Aquestive Therapeutics (NASDAQ: AQST)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Aquestive Therapeutics (NASDAQ: AQST) through any online brokerage.
The latest price target for Aquestive Therapeutics (NASDAQ: AQST) was reported by HC Wainwright & Co. on Tuesday, June 21, 2022. The analyst firm set a price target for 5.00 expecting AQST to rise to within 12 months (a possible 468.18% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $0.88 last updated August 5, 2022, 8:00 PM UTC.
There are no upcoming dividends for Aquestive Therapeutics.
Aquestive Therapeutics’s Q3 earnings are confirmed for Tuesday, November 1, 2022.
There is no upcoming split for Aquestive Therapeutics.
Aquestive Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.